BRIEF published on 04/13/2026 at 08:05, 5 months 16 days ago Transgene conclut la randomisation des patients dans la phase 2 de l'essai clinique TG4050 Cancer De La Tête Et Du Cou Essai Clinique De Phase 2 Transgene Vaccin TG4050 Survie Sans Maladie
BRIEF published on 04/13/2026 at 07:35, 5 months 16 days ago Infoclip annonce un projet de changement de contrôle Offre Publique De Retrait Changement De Contrôle Infoclip RIVAGE GROUPE Laurent Azoulay
BRIEF published on 04/13/2026 at 07:35, 5 months 16 days ago Infoclip announces a proposed change of control Change Of Control Public Delisting Offer Infoclip Laurent Azoulay RIVAGE GROUP
BRIEF published on 04/13/2026 at 07:05, 5 months 16 days ago Burkhalter Group's Robust 2025 Financial Performance Surpasses Expectations Financial Performance Acquisitions Dividend Increase Market Outlook Sustainability Initiatives
BRIEF published on 04/13/2026 at 07:05, 5 months 16 days ago Les solides performances financières du groupe Burkhalter en 2025 dépassent les attentes. Acquisitions Performance Financière Perspectives Du Marché Augmentation Des Dividendes Initiatives De Développement Durable
BRIEF published on 04/13/2026 at 07:05, 5 months 16 days ago Swiss Re Releases 2025 Financial Condition Report Reinsurance Risk Management Swiss Re Financial Condition Solvency
BRIEF published on 04/13/2026 at 07:05, 5 months 16 days ago Swiss Re publie son rapport sur la situation financière pour 2025 Réassurance Swiss Re Gestion Des Risques Situation Financière Solvabilité
BRIEF published on 04/13/2026 at 07:05, 5 months 16 days ago 20 Years of Biosimilar Medicines: Sandoz Celebrates a Milestone Biosimilars Healthcare Savings Patient Access Omnitrope Patent Expiries
BRIEF published on 04/13/2026 at 07:05, 5 months 16 days ago 20 ans de médicaments biosimilaires : Sandoz célèbre une étape importante Biosimilaires Accès Des Patients Omnitrope Économies En Soins De Santé Expiration Des Brevets
BRIEF published on 04/13/2026 at 07:05, 5 months 16 days ago BioVersys Advances Tuberculosis Treatment with AlpE Drug Resistance BioVersys Tuberculosis Alpibectir Ethionamide
Published on 09/29/2026 at 09:01, 28 minutes ago Star Copper Advances Western Extension Drilling at Star Main
Published on 09/29/2026 at 06:45, 2 hours 44 minutes ago Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Published on 09/29/2026 at 04:36, 4 hours 53 minutes ago The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)
Published on 09/29/2026 at 02:30, 6 hours 59 minutes ago QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 00:00, 9 hours 29 minutes ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/29/2026 at 09:05, 24 minutes ago Advanet Introduces Renesas RZ/G3L-Based Industrial Computing Product Family
Published on 09/29/2026 at 09:00, 29 minutes ago Bitcoin Group SE publishes Half-Year Report 2026: Focus on relaunch of bitcoin.de with significantly expanded product offering
Published on 09/29/2026 at 08:45, 44 minutes ago Cegedim Santé réinvente l’accès à l’information médicale en déployant l’Assistant by Claude Bernard IA sur toutes ses solutions de médecine de ville
Published on 09/28/2026 at 17:54, 15 hours 34 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 15 hours 34 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 15 hours 44 minutes ago Déclaration hebdomadaire de rachat d'actions
